COMMUNIQUÉS West-GlobeNewswire

-
Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results
07/02/2019 -
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results
07/02/2019 -
Portola Pharmaceuticals Announces Full Results from the ANNEXA-4 Study of the Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Life-Threatening Bleeding
07/02/2019 -
IntelGenx Strengthens Senior Management Team
07/02/2019 -
Cytokinetics to Announce Fourth Quarter Results on February 21, 2019
07/02/2019 -
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending 31 December 2018 and Host Conference Call on 26 February 2019
07/02/2019 -
Participation de Merus au forum d’échange sur les soins de santé de Guggenheim
07/02/2019 -
Tetra Bio-Pharma Pursues Its Research Priorities Accelerating Other Drug Development Plans
07/02/2019 -
Avadel Pharmaceuticals Clarifies Announcement of Corporate Restructuring
07/02/2019 -
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
07/02/2019 -
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/02/2019 -
OSE Immunotherapeutics and Servier Announce First Option Within Global License Agreement Exercised for Further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases
07/02/2019 -
Vital® Spotlights True Interoperability at HIMSS 2019 and Celebrates a KLAS No. 1 Ranking for Advanced Visualization
07/02/2019 -
Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on February 21, 2019
07/02/2019 -
Coherus BioSciences Announces New Employment Inducement Grants
07/02/2019 -
Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities
07/02/2019 -
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts
07/02/2019 -
Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm
07/02/2019 -
Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks
07/02/2019
Pages